Zyla Life Sciences Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 12 rows in 2018. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2018-07-02: Reporting owner Varian John; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2018-05-14: Reporting owner WEAVER GREGORY L; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2018-05-14: Reporting owner Walbert Timothy P; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2018-05-14: Reporting owner OSBORN JOHN E; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2018-07-02 | Varian John Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +110,000 110,000 owned after | $0.40 exercise price | 2018-07-02 | |
| 2018-05-14 | WEAVER GREGORY L Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +75,000 75,000 owned after | $0.60 exercise price | 2018-05-15 | |
| 2018-05-14 | Walbert Timothy P Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +75,000 75,000 owned after | $0.60 exercise price | 2018-05-15 | |
| 2018-05-14 | OSBORN JOHN E Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +75,000 75,000 owned after | $0.60 exercise price | 2018-05-15 | |
| 2018-05-14 | Smiley Andrea Heslin Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +75,000 75,000 owned after | $0.60 exercise price | 2018-05-15 | |
| 2018-05-14 | ROCHE ROBERT P JR Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +75,000 75,000 owned after | $0.60 exercise price | 2018-05-15 | |
| 2018-05-14 | Hochberg Elaine Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +75,000 75,000 owned after | $0.60 exercise price | 2018-05-15 | |
| 2018-05-14 | NICOLAIDES NICHOLAS C Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +75,000 75,000 owned after | $0.60 exercise price | 2018-05-15 | |
| 2018-03-08 holding as of filing | TIMMINS MEGAN C. Officer (General Counsel) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $5.43 exercise price | 2018-03-08 | ||
| 2018-03-08 holding as of filing | TIMMINS MEGAN C. Officer (General Counsel) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $7.96 exercise price | 2018-03-08 | ||
| 2018-03-08 holding as of filing | TIMMINS MEGAN C. Officer (General Counsel) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $2.38 exercise price | 2018-03-08 | ||
| 2018-03-08 holding as of filing | TIMMINS MEGAN C. Officer (General Counsel) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $1.29 exercise price | 2018-03-08 |